论人类胚胎干细胞发明的可专利性

发布时间：2018-05-12 06:59

本文选题：人类胚胎干细胞 + 人类胚胎干细胞发明　；参考：《华中科技大学》2012年硕士论文

【摘要】：目前，世界上很多国家都鼓励和支持人类胚胎干细胞的研究，，但大多数国家都对人类胚胎干细胞的可专利性问题采取否定的态度，其理由主要是基于伦理道德的考虑。但是随着科学技术的不断发展，传统专利制度所保护的客体范围受到了挑战。在生物技术领域，人类胚胎干细胞技术的快速发展和其极大的医疗价值引起了人们极大的关注。由于人类胚胎干细胞发明被排除在专利保护之外，许多新的人类胚胎干细胞技术不能得到专利制度的保护。将人类胚胎干细胞发明完全排除在专利保护之外将随着人类胚胎干细胞技术的发展受到越来越大的挑战，实务中也陆续出现了关于人类胚胎干细胞发明可专利性的案例，这些案例的出现也引发了强烈的理论和实务上的争议。因此我们有必要重新审视关于人类胚胎干细胞发明可专利性的问题。本文首先介绍了胚胎干细胞的基本知识，并概括出人类胚胎干细胞发明可专利性的障碍所在；然后对人类胚胎干细胞研究行为的法律管制现状和专利保护现状进行总结述评，以观察各国对于人类胚胎干细胞研究的态度；接着分别从可专利主题和实质授权要件两个方面对人类胚胎干细胞发明的可专利性进行分析，得出了人类胚胎干细胞发明专利保护可行的结论；最后对我国现有专利制度对于人类胚胎干细胞发明的适用进行分析，并提出相关建议。
[Abstract]:At present, many countries in the world have encouraged and supported the research of human embryonic stem cells, but most countries take a negative attitude towards the patentability of human embryonic stem cells. The reason is mainly based on ethical considerations. However, with the continuous development of science and technology, the scope of the object protected by the traditional patent system is subject to the scope. Challenges. In the field of biotechnology, the rapid development of human embryonic stem cell technology and its great medical value have aroused great concern. Since the invention of human embryonic stem cells is excluded from patent protection, many new human embryonic stem cell technologies can not be protected by the special benefit system. The invention of human embryonic stem cells is the invention. With the development of human embryonic stem cells (embryonic stem cells), the patent protection of human embryonic stem cells is becoming more and more challenging. In practice, there have been some cases about the patentability of human embryonic stem cells. The emergence of these cases has also triggered a strong theoretical and practical controversy. The invention of the patentable problem of human embryonic stem cells.
This paper first introduces the basic knowledge of embryonic stem cells, and summarizes the obstacles to the invention of the patentability of human embryonic stem cells, and then reviews the status of the legal regulation of human embryonic stem cell research and the status of patent protection in order to observe the attitudes of countries to the research of human embryonic stem cells. The patentability of the invention of human embryonic stem cells is analyzed in two aspects: the patentable theme and the essential element of authorization. The feasible conclusion of the invention patent protection of human embryonic stem cells is drawn. Finally, the application of the existing patent system in China on the invention of human embryonic stem cells is analyzed and some relevant suggestions are put forward.

【学位授予单位】：华中科技大学
【学位级别】：硕士
【学位授予年份】：2012
【分类号】：R329.2;D923.42

【参考文献】